196 related articles for article (PubMed ID: 30232998)
1. Antibodies to Zika virus,
Baskar D; Amalnath D; Mandal J; Dhodapkar R; Vanathi K
Neurol India; 2018; 66(5):1324-1331. PubMed ID: 30232998
[TBL] [Abstract][Full Text] [Related]
2. Ambiguous value of anti-ganglioside IgM autoantibodies in Guillain-Barré syndrome and its variants.
Koga M; Takahashi M; Yokoyama K; Kanda T
J Neurol; 2015 Aug; 262(8):1954-60. PubMed ID: 26050638
[TBL] [Abstract][Full Text] [Related]
3. Anti-ganglioside antibodies in patients with Zika virus infection-associated Guillain-Barré Syndrome in Brazil.
Rivera-Correa J; de Siqueira IC; Mota S; do Rosário MS; Pereira de Jesus PA; Alcantara LCJ; Ernst JD; Rodriguez A
PLoS Negl Trop Dis; 2019 Sep; 13(9):e0007695. PubMed ID: 31527907
[TBL] [Abstract][Full Text] [Related]
4. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N
Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to dengue, Zika,
Sookaromdee P; Wiwanitkit V
Neurol India; 2019; 67(1):335. PubMed ID: 30860160
[No Abstract] [Full Text] [Related]
6. Longitudinal changes of anti-ganglioside antibodies before and after Guillain-Barré syndrome onset subsequent to Campylobacter jejuni enteritis.
Odaka M; Koga M; Yuki N; Susuki K; Hirata K
J Neurol Sci; 2003 Jun; 210(1-2):99-103. PubMed ID: 12736097
[TBL] [Abstract][Full Text] [Related]
7. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
[TBL] [Abstract][Full Text] [Related]
8. Guillain-Barré syndrome-related Campylobacter jejuni in Bangladesh: ganglioside mimicry and cross-reactive antibodies.
Islam Z; Gilbert M; Mohammad QD; Klaij K; Li J; van Rijs W; Tio-Gillen AP; Talukder KA; Willison HJ; van Belkum A; Endtz HP; Jacobs BC
PLoS One; 2012; 7(8):e43976. PubMed ID: 22952833
[TBL] [Abstract][Full Text] [Related]
9. Antecedent infections in Guillain-Barré syndrome in endemic areas of arbovirus transmission: A multinational case-control study.
Leonhard SE; Tan CY; van der Eijk AA; Reisin RR; Franken SC; Huizinga R; Arends S; Batstra MR; Bezerra Jeronimo SM; Drenthen J; de Koning L; Leon Cejas L; Marchesoni C; Marques W; Shahrizaila N; Casas DF; Sotelo A; Tillard B; Dourado ME; Jacobs BC
J Peripher Nerv Syst; 2021 Dec; 26(4):449-460. PubMed ID: 34549484
[TBL] [Abstract][Full Text] [Related]
10. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain-Barré syndrome and in other neuroimmunological disorders.
Enders U; Karch H; Toyka KV; Michels M; Zielasek J; Pette M; Heesemann J; Hartung HP
Ann Neurol; 1993 Aug; 34(2):136-44. PubMed ID: 8338338
[TBL] [Abstract][Full Text] [Related]
11. Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barré and Fisher's syndromes.
Koga M; Yuki N; Takahashi M; Saito K; Hirata K
J Neuroimmunol; 1998 Jan; 81(1-2):138-43. PubMed ID: 9521615
[TBL] [Abstract][Full Text] [Related]
12. Subclass distribution and the secretory component of serum IgA anti-ganglioside antibodies in Guillain-Barré syndrome after Campylobacter jejuni enteritis.
Koga M; Yuki N; Hirata K
J Neuroimmunol; 1999 May; 96(2):245-50. PubMed ID: 10337924
[TBL] [Abstract][Full Text] [Related]
13. Preceding infections and anti-ganglioside antibody profiles assessed by a dot immunoassay in 306 French Guillain-Barré syndrome patients.
Caudie C; Quittard Pinon A; Taravel D; Sivadon-Tardy V; Orlikowski D; Rozenberg F; Sharshar T; Raphaël JC; Gaillard JL
J Neurol; 2011 Nov; 258(11):1958-64. PubMed ID: 21516465
[TBL] [Abstract][Full Text] [Related]
14. Antibodies to gangliosides and galactocerebroside in patients with Guillain-Barré syndrome with preceding Campylobacter jejuni and other identified infections.
Hao Q; Saida T; Kuroki S; Nishimura M; Nukina M; Obayashi H; Saida K
J Neuroimmunol; 1998 Jan; 81(1-2):116-26. PubMed ID: 9521613
[TBL] [Abstract][Full Text] [Related]
15. Augmented Zika and Dengue Neutralizing Antibodies Are Associated With Guillain-Barré Syndrome.
Lynch RM; Mantus G; Encinales L; Pacheco N; Li G; Porras A; Mendoza AR; Peng J; Rengifo-Pardo M; Cruz MM; Harris E; Bethony JM; Simon GL; Chang AY
J Infect Dis; 2019 Jan; 219(1):26-30. PubMed ID: 30113672
[TBL] [Abstract][Full Text] [Related]
16. Origin of ganglioside complex antibodies in Guillain-Barré syndrome.
Kuijf ML; Godschalk PC; Gilbert M; Endtz HP; Tio-Gillen AP; Ang CW; van Doorn PA; Jacobs BC
J Neuroimmunol; 2007 Aug; 188(1-2):69-73. PubMed ID: 17604126
[TBL] [Abstract][Full Text] [Related]
17. Recurrent Guillain-Barré Syndrome Associated with the Second Episode of Campylobacter jejuni Infection.
Takemoto K; Kawahara M; Atagi K
Intern Med; 2023 Oct; 62(20):3037-3041. PubMed ID: 36858520
[TBL] [Abstract][Full Text] [Related]
18. Does Campylobacter jejuni infection elicit "demyelinating" Guillain-Barre syndrome?
Kuwabara S; Ogawara K; Misawa S; Koga M; Mori M; Hiraga A; Kanesaka T; Hattori T; Yuki N
Neurology; 2004 Aug; 63(3):529-33. PubMed ID: 15304587
[TBL] [Abstract][Full Text] [Related]
19. Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndrome.
Schessl J; Koga M; Funakoshi K; Kirschner J; Muellges W; Weishaupt A; Gold R; Korinthenberg R
Arch Dis Child; 2007 Jan; 92(1):48-52. PubMed ID: 16920757
[TBL] [Abstract][Full Text] [Related]
20. Seroreactivity to Campylobacter jejuni and gangliosides in patients with Guillain-Barré syndrome.
von Wulffen H; Hartard C; Scharein E
J Infect Dis; 1994 Oct; 170(4):828-33. PubMed ID: 7930724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
